Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Translational Lung Cancer Research|April 15, 2015
Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancerPo Yee Yip
Internal Medicine Journal|August 31, 2022
Outcomes of extensive stage extrapulmonary small cell cancerGeovanny Gandy, Po Yee Yip, Annette Tognela, et al.
Asia-Pacific Journal of Clinical Oncology|June 18, 2025
Real-World Survival Outcomes of Patients With High PD-L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus ImmunotherapyJunipearl Cheng, Charlotte McKay, Victoria Bray, et al.
FEBS Letters|March 21, 2002
Tandem termination signals: myth or reality?Louise L Major, Tina D Edgar, Po Yee Yip, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2023
Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumabUdit Nindra, Adel Shahnam, Samuel Stevens, et al.
Thoracic Cancer|September 16, 2022
Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poorer progression-free survival in unresectable stage III NSCLC treated with consolidation durvalumabUdit Nindra, Adel Shahnam, Samuel Stevens, et al.
Critical Reviews in Oncology/Hematology|December 3, 2014
Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspectiveAnnette Tognela, Kevin J Spring, Therese Becker, et al.
The Prostate|March 25, 2011
Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancerPo Yee Yip, James G Kench, Krishan K Rasiah, et al.
Pathology|November 19, 2025
Histopathological associations, molecular findings and clinical outcomes of patients with non-small cell lung carcinoma with MET alterations: a 3-year retrospective Australian case seriesJing Jing Li, Jawad Saab, Victoria Bray, et al.
Pathology|June 25, 2024
The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinomaJing Jing Li, Xiao Juan Wu, Mahtab Farzin, et al.
Pageof 2